Stockscreener 앱 받기
14.83
6.95%
-1.1543
전일 마감가:
$15.98
열려 있는:
$15.79
하루 거래량:
477.74K
Relative Volume:
0.92
시가총액:
$807.80M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-12.99%
1개월 성능:
-12.73%
6개월 성능:
+2.55%
1년 성능:
-40.45%
1일 변동 폭
$14.50
$16.11
1주일 범위
$14.50
$17.25
52주 변동 폭
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
명칭
Bicara Therapeutics Inc
전화
617-468-4219
주소
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
14.80 | 872.71M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.52 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
626.68 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.19 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.24 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-05-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 개시 | Wells Fargo | Underweight |
| 2025-02-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-08 | 개시 | TD Cowen | Buy |
모두보기
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
Should I hold or sell Bicara Therapeutics Inc. stock in 2025Weekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Real time alert setup for Bicara Therapeutics Inc. performanceWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
What dividend safety score for Bicara Therapeutics Inc. stock2025 Historical Comparison & Reliable Price Breakout Signals - newser.com
Why Bicara Therapeutics Inc. stock appeals to analystsJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Will Bicara Therapeutics Inc. stock see insider buyingJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
What risks investors should watch in Bicara Therapeutics Inc. stockPortfolio Return Report & Weekly High Momentum Picks - newser.com
Is Bicara Therapeutics Inc. stock a buy before product launchesFed Meeting & Safe Capital Growth Stock Tips - newser.com
How Bicara Therapeutics Inc. stock benefits from global expansion2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Is Bicara Therapeutics Inc. stock safe for conservative investors2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
How to manage a losing position in Bicara Therapeutics Inc.Jobs Report & Technical Pattern Based Buy Signals - newser.com
How currency fluctuations impact Bicara Therapeutics Inc. stock2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
Analyzing Bicara Therapeutics Inc. with risk reward ratio charts2025 Macro Impact & AI Driven Stock Movement Reports - newser.com
How Bicara Therapeutics Inc. stock compares to market leadersBreakout Watch & Precise Swing Trade Entry Alerts - newser.com
Why Bicara Therapeutics Inc. stock is considered a top pickTrade Ideas & Safe Capital Preservation Plans - newser.com
How institutional buying supports Bicara Therapeutics Inc. stockPortfolio Update Report & Verified Momentum Stock Alerts - newser.com
Will Bicara Therapeutics Inc. stock benefit from automationJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
What institutional flow reveals about Bicara Therapeutics Inc.Earnings Beat & Risk Controlled Stock Alerts - newser.com
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.18%
0.56%
자본화:
|
볼륨(24시간):